TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com
Equities researchers at StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Get Free Report) in a research note issued to investors on Wednesday. The firm set a “hold” rating on the stock. TherapeuticsMD Stock Up 5.6 % TXMD stock opened at $1.14 on Wednesday. TherapeuticsMD has a one year low of $0.70 and a […]
